Main > ENDOCRINOLOGY > Diabetes. Treatment > SitaGliptin+Metformin.HCl Combi. > Co.: USA. M. (Brand Tablet/Patent)

---

Co.: USA. M. (Brand Tablet/Patent)'s subsections
Company
Dosages per Tablet>
Patent>DisClosure
Patent>Total USA No.: 1
Patent>UpDate: 06.05.07
Patent>USA Expiration: 07.05.2022
Status>EU>Approval Recommendation
Status>USA>Approved
TradeMark
UpDate: 04.24.08
Web-Site

Co.: USA. M. (Brand Tablet/Patent)'s products
This section has no products